Elevance Health Q2 EPS Forecast Reduced by Zacks Research
Elevance Health, Inc. (NYSE:ELV – Free Report) – Research analysts at Zacks Research dropped their Q2 2026 earnings estimates for Elevance Health in a research report issued on Wednesday, May 6th. Zacks Research analyst Team now expects that the company will post earnings per share of $6.15 for the quarter, down from their previous estimate […]
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.